Matthias Stoll

5.3k total citations
104 papers, 3.2k citations indexed

About

Matthias Stoll is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Matthias Stoll has authored 104 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 48 papers in Infectious Diseases and 19 papers in Virology. Recurrent topics in Matthias Stoll's work include HIV/AIDS drug development and treatment (28 papers), HIV/AIDS Research and Interventions (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (20 papers). Matthias Stoll is often cited by papers focused on HIV/AIDS drug development and treatment (28 papers), HIV/AIDS Research and Interventions (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (20 papers). Matthias Stoll collaborates with scholars based in Germany, United States and Austria. Matthias Stoll's co-authors include Reinhold Schmidt, Georg M. N. Behrens, Dominik Begerow, Hartmut Schmidt, Michael P. Manns, Hans L. Tillmann, Johann Ockenga, Franz Oberwinkler, Robert Bauer and André Dejam and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Matthias Stoll

101 papers receiving 3.1k citations

Peers

Countries citing papers authored by Matthias Stoll

Since Specialization

Citations

This map shows the geographic impact of Matthias Stoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Stoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Stoll more than expected).

Fields of papers citing papers by Matthias Stoll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Stoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Stoll. The network helps show where Matthias Stoll may publish in the future.

Co-authorship network of co-authors of Matthias Stoll

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Stoll. A scholar is included among the top collaborators of Matthias Stoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Stoll. Matthias Stoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018) 2021 ·BMC Public Health ·(unknown), Daniel Schmidt, (unknown), Christian Kollan, Matthias Stoll, Osamah Hamouda, Viviane Bremer, Tobias Kurth, Barbara Gunsenheimer‐Bartmeyer	5
2	Chronic Granulomatous Disease First Diagnosed in Adulthood Presenting With Spinal Cord Infection 2018 ·Frontiers in Immunology ·Philipp Schwenkenbecher, Alexandra Neyazi, Frank Donnerstag, Felix C. Ringshausen, Roland Jacobs, Matthias Stoll, Paul A. Kirschner, Florian Länger, (unknown), Stefan Gingele, Florian Wegner, Kurt‐Wolfram Sühs, Martin Stangel, Thomas Skripuletz	7
3	Unemployment, health, and education of HIV-infected males in Germany 2015 ·International Journal of Public Health ·(unknown), Annika Herr, Martin Hower, Alexander Kuhlmann, Jörg Mahlich, Matthias Stoll	19
4	Importance of Follow-Up Cerebrospinal Fluid Analysis in Cryptococcal Meningoencephalitis 2014 ·Disease Markers ·Thomas Skripuletz, Philipp Schwenkenbecher, Kaweh Pars, Matthias Stoll, (unknown), (unknown), Refik Pul, Ralf‐Peter Vonberg, Ludwig Sedlacek, Ulrich Wurster, Martin Stangel, Corinna Trebst	26
5	Veno-venous extracorporeal membrane oxygenation therapy of a severely injured patient after secondary survey 2014 ·The American Journal of Emergency Medicine ·Matthias Stoll, (unknown), (unknown), Justus Strauch, Thomas A. Schildhauer, Justyna Swol	6
6	Häufigkeiten antiretroviraler Therapie in Sekundärdaten von gesetzlichen Krankenkassen in Deutschland 2014 ·Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen ·(unknown), Jörg Mahlich, Matthias Stoll	2
7	Timing of first shoot topping and its impact on grapevine canopy and cluster morphology as well as on susceptibility to bunch rot. 2013 ·Journal of Plant Pathology ·(unknown), Daniel Molitor, Marc Behr, (unknown), Thomas Udelhoven, Matthias Stoll, Danièle Evers	1
8	Patient preferences for HIV/AIDS therapy - a discrete choice experiment 2013 ·Health Economics Review ·Axel Mühlbacher, Matthias Stoll, Jörg Mahlich, Matthias Nübling	36
9	Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection 2012 ·PLoS ONE ·Jerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer‐Olson, Stefan Mauss, Martin Vogel, Patrick Ingiliz, B.A. Payer, Matthias Stoll, Michael P. Manns, Reinhold Schmidt, Robert Flisiak, Heiner Wedemeyer, Markus Peck‐Radosavljevic, Jürgen K. Rockstroh, Markus Cornberg	40
10	Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients 2010 ·PharmacoEconomics ·Andrew Hill, Bonaventura Clotet, Margaret Johnson, Matthias Stoll, (unknown), (unknown)	3
11	Cost impact of prospective HLA-B5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany 2010 ·European journal of medical research* ·Eva Wolf, Markus Blankenburg, Johannes R. Bogner, Werner J. Becker, (unknown), (unknown), H. Jaeger, R Welte, (unknown), (unknown), Matthias Stoll	20
12	Akutes Nierenversagen und Hyperkalzämie unter tenofovirhaltiger antiretroviraler Therapie bei einer Patientin mit AIDS und Immunrekonstitutionssyndrom nach niedrigdosierter Vitamin-D-Substitution 2009 ·Medizinische Klinik ·(unknown), (unknown), Reinhold Schmidt, Matthias Stoll	2
13	Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patients. 2007 ·PubMed ·Bernd Salzberger, Martin Däumer, Peter Gute, H. Jaeger, Heribert Knechten, (unknown), Stefan Mauss, Christoph Mayr, Anthony P. Moll, Andreas Plettenberg, Jürgen K. Rockstroh, S Staszewski, (unknown), Matthias Stoll, Martin Stürmer	3
14	Molecular phylogeny of Ustilago, Sporisorium, and related taxa based on combined analyses of rDNA sequences 2005 ·Mycological Research ·Matthias Stoll, Dominik Begerow, Franz Oberwinkler	82
15	Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe 2005 ·Journal of Infection ·Markus Rihl, Matthias Stoll, Kai U. Ulbricht, Franz‐Christoph Bange, (unknown)	24
16	Successful tumor necrosis factor α blockade treatment in therapy‐resistant sarcoidosis 2003 ·Arthritis & Rheumatism ·Kai U. Ulbricht, Matthias Stoll, (unknown), Torsten Witte, Reinhold Schmidt	59
17	Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease 2003 ·AIDS ·Georg M. N. Behrens, Dirk Meyer‐Olson, Matthias Stoll, Reinhold Schmidt	35
18	Immunrekonstitutionssyndrom 2002 ·DMW - Deutsche Medizinische Wochenschrift ·Matthias Stoll, (unknown), Reinhold E. Schmidt	1
19	Immune Reconstitution Syndromes in Human Immunodeficiency Virus Infection Following Effective Antiretroviral Therapy 2000 ·Immunobiology ·Georg M. N. Behrens, Dirk Meyer, Matthias Stoll, Reinhold Schmidt	33
20	Human Papillomavirus Testing in Primary Screening for Cervical Cancer of Human Immunodeficiency Virus-Infected Women, 1990–1998 1999 ·Gynecologic Oncology ·Karl Ulrich Petry, Gerd Böhmer, Thomas Iftner, Peer Flemming, Matthias Stoll, Reinhold Schmidt	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact